Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
412303: etest ceftriaxone - spb packaging as a part of our ongoing thorough analysis of the etest product range we have observed internally two issues with etest ceftriaxone txl32 (ref. 412303) spb packaging that may affect the test performance. 507018 : etest ceftriaxone txl32 - foam packaging: as a part of our ongoing thorough analysis of the etest product range we have observed internally two issues with etest ceftriaxone txl32 (ref. 507018) foam that may affect the test performance.